These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 826828)

  • 21. [Functional lymphoma capable of restoring the thymic response of an allogeneic mouse].
    Piazzon I; Déroche A; Matusevich M; Pasqualini CD
    Medicina (B Aires); 1979; 39(3):351-6. PubMed ID: 42002
    [No Abstract]   [Full Text] [Related]  

  • 22. Effect of bacille Calmette-Guérin on the immune response of BALB/c mice to a tumor allograft.
    Treagan L; Chen TH; Rambo O; Elberg SS
    J Infect Dis; 1979 Oct; 140(4):541-5. PubMed ID: 117062
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Method of efficacious immunization against syngeneic murine sarcoma].
    Schaaf-Lafontaine N; Maquet P; De Graef-Lovens D; Courtoy R; Firket H
    C R Seances Soc Biol Fil; 1985; 179(1):122-7. PubMed ID: 3161594
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunologic enhancement induced by antibody fragments.
    Cruse JM; Forbes JT; Gillespie GY; Lewis GK
    Z Immunitatsforsch Allerg Klin Immunol; 1970; 140(3):259-67. PubMed ID: 4251393
    [No Abstract]   [Full Text] [Related]  

  • 25. Antigenic inhibition of cell-mediated cytotoxicity against tumour cells.
    Shellam GR; Knight RA
    Nature; 1974 Nov; 252(5481):330-2. PubMed ID: 4372543
    [No Abstract]   [Full Text] [Related]  

  • 26. Facilitation of macrophage-mediated destruction of allogeneic fibrosarcoma cells by tumor-enhancing IgG 2 in vitro.
    Cruse JM; Whitten HD; Lewis GK; Watson ES
    Transplant Proc; 1973 Mar; 5(1):961-7. PubMed ID: 4695960
    [No Abstract]   [Full Text] [Related]  

  • 27. Relationships among differentiated T-cell subpopulations. IV. Preferential induction of delayed footpad reaction to xenografts and its radioresistant nature.
    Terasaka R; Nomoto K; Himeno K; Takeya T
    Immunology; 1979 Apr; 36(4):699-705. PubMed ID: 312268
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunologic enhancement induced by 7S antibody globulin.
    Cruse JM; Azar MM
    Z Immunitatsforsch Allerg Klin Immunol; 1967 Mar; 132(3):240-6. PubMed ID: 4232737
    [No Abstract]   [Full Text] [Related]  

  • 29. Quantitative effects of nutritional protein and calorie deficiency upon immune responses to tumors in mice.
    Jose DG; Good RA
    Cancer Res; 1973 Apr; 33(4):807-12. PubMed ID: 4633154
    [No Abstract]   [Full Text] [Related]  

  • 30. Lack of correlation between in vivo rejection of syngeneic fibrosarcomas and in vitro non-specific macrophage cytotoxicity.
    Evans R; Booth CG; Spencer F
    Br J Cancer; 1978 Nov; 38(5):583-90. PubMed ID: 310310
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Allograft cytotoxicity. Role of T lymphocytes bearing a receptor for complement.
    Arnaiz-Villena A; Jones B; Roitt IM
    Immunology; 1975 Nov; 29(5):903-8. PubMed ID: 811554
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lysis of syngeneic solid tumor cells by alloantigen stimulated mouse T and non-T cells.
    Paciucci PA; Macphail S; Zarling JM; Bach FH
    J Immunol; 1980 Jan; 124(1):370-5. PubMed ID: 6765969
    [No Abstract]   [Full Text] [Related]  

  • 33. Specific and nonspecific antitumor immunity. III. Specific T lymphocyte-mediated cytolysis of P815 mastocytoma and SL2 lymphoma by draining lymph node cells from syngeneic tumor-bearing DBA/2J mice.
    Germain RN; Williams RM; Benacerraf B
    Am J Pathol; 1976 Dec; 85(3):661-74. PubMed ID: 826167
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Tumor enhancing T lymphocytes in mice: further studies on characteristics and mechanism of activity.
    Small M
    Int J Cancer; 1982 Apr; 29(4):465-9. PubMed ID: 6979522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Corynebacterium parvum as a therapeutic antitumor agent in mice. II. Local injection.
    Scott MT
    J Natl Cancer Inst; 1974 Sep; 53(3):861-5. PubMed ID: 4213016
    [No Abstract]   [Full Text] [Related]  

  • 36. Potentiation of cytotoxic T-cell function by virus.
    Reinisch CL; Schlossman SF
    J Natl Cancer Inst; 1976 Dec; 57(6):1277-81. PubMed ID: 63565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell-mediated immune responses in vitro. I. Suppression of the generation of cytotoxic lymphocytes by concanavalin A and concanavalin A-activated spleen cells.
    Peavy DL; Pierce CW
    J Exp Med; 1974 Aug; 140(2):356-69. PubMed ID: 4276949
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Use of Vaccinia virus as an adjuvant in inducing specific anti-tumour immunity to transplantable mouse fibrosarcoma. II. Rejection of tumour graft 'in vivo' humoral and lymphocytotoxicity 'in vitro'.
    Bendre AR; Gangal SG
    Indian J Cancer; 1978 Dec; 15(4):9-16. PubMed ID: 757692
    [No Abstract]   [Full Text] [Related]  

  • 39. Specificity and longevity of antitumor immune responses induced by B7-transfected tumors.
    Townsend SE; Su FW; Atherton JM; Allison JP
    Cancer Res; 1994 Dec; 54(24):6477-83. PubMed ID: 7527298
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Rejection mechanisms of xenogeneic tissue antigens in mice (author's transl)].
    Terasaka R
    Fukuoka Igaku Zasshi; 1980 Jul; 71(7):365-81. PubMed ID: 6971245
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.